stocks logo

AVNS Valuation

Avanos Medical Inc
$
11.940
+0.07(0.590%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

AVNS Relative Valuation

AVNS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AVNS is overvalued; if below, it's undervalued.
Intellectia AI SwingMax

Historical Valuation

Avanos Medical Inc (AVNS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.74 is considered Undervalued compared with the five-year average of 20.45. The fair price of Avanos Medical Inc (AVNS) is between 16.27 to 29.48 according to relative valuation methord. Compared to the current price of 11.94 USD , Avanos Medical Inc is Undervalued By 26.6%.
Relative Value
Fair Zone
16.27-29.48
Current Price:11.94
26.6%
Undervalued
14.74
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Avanos Medical Inc. (AVNS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 10.99. The thresholds are as follows: Strongly Undervalued below -0.58, Undervalued between -0.58 and 5.20, Fairly Valued between 16.78 and 5.20, Overvalued between 16.78 and 22.56, and Strongly Overvalued above 22.56. The current Forward EV/EBITDA of 0.00 falls within the Undervalued range.
0.00
EV/EBIT
Avanos Medical Inc. (AVNS) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 14.63. The thresholds are as follows: Strongly Undervalued below 0.15, Undervalued between 0.15 and 7.39, Fairly Valued between 21.87 and 7.39, Overvalued between 21.87 and 29.11, and Strongly Overvalued above 29.11. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.82
PS
Avanos Medical Inc. (AVNS) has a current PS of 0.82. The 5-year average PS is 1.68. The thresholds are as follows: Strongly Undervalued below 0.46, Undervalued between 0.46 and 1.07, Fairly Valued between 2.28 and 1.07, Overvalued between 2.28 and 2.89, and Strongly Overvalued above 2.89. The current Forward PS of 0.82 falls within the Undervalued range.
0.00
P/OCF
Avanos Medical Inc. (AVNS) has a current P/OCF of 0.00. The 5-year average P/OCF is 14.62. The thresholds are as follows: Strongly Undervalued below -7.50, Undervalued between -7.50 and 3.56, Fairly Valued between 25.68 and 3.56, Overvalued between 25.68 and 36.74, and Strongly Overvalued above 36.74. The current Forward P/OCF of 0.00 falls within the Undervalued range.
0.00
P/FCF
Avanos Medical Inc. (AVNS) has a current P/FCF of 0.00. The 5-year average P/FCF is 27.90. The thresholds are as follows: Strongly Undervalued below -95.25, Undervalued between -95.25 and -33.67, Fairly Valued between 89.48 and -33.67, Overvalued between 89.48 and 151.06, and Strongly Overvalued above 151.06. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Avanos Medical Inc (AVNS) has a current Price-to-Book (P/B) ratio of 0.71. Compared to its 3-year average P/B ratio of 0.81 , the current P/B ratio is approximately -11.57% higher. Relative to its 5-year average P/B ratio of 1.02, the current P/B ratio is about -30.42% higher. Avanos Medical Inc (AVNS) has a Forward Free Cash Flow (FCF) yield of approximately 15.87%. Compared to its 3-year average FCF yield of 6.50%, the current FCF yield is approximately 144.17% lower. Relative to its 5-year average FCF yield of 4.45% , the current FCF yield is about 256.91% lower.
0.71
P/B
Median3y
0.81
Median5y
1.02
15.87
FCF Yield
Median3y
6.50
Median5y
4.45
Financial AI Agent

Competitors Valuation Multiple

The average P/S ratio for AVNS's competitors is 1.34, providing a benchmark for relative valuation. Avanos Medical Inc Corp (AVNS) exhibits a P/S ratio of 0.82, which is -38.62% above the industry average. Given its robust revenue growth of 1.92%, this premium appears unsustainable.
AI Stock Picker

Performance Decomposition

1Y
3Y
5Y
Market capitalization of AVNS decreased by 50.31% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.06 to -1.19.
The secondary factor is the Revenue Growth, contributed 1.92%to the performance.
Overall, the performance of AVNS in the past 1 year is driven by P/E Change. Which is more unsustainable.
1.92%
171.70M → 175.00M
Revenue Growth
+
-1855.60%
2.50 → -43.89
Margin Expansion
+
1803.37%
-0.06 → -1.19
P/E Change
=
-50.31%
24.03 → 11.94
Mkt Cap Growth

FAQ

arrow icon

Is Avanos Medical Inc (AVNS) currently overvalued or undervalued?

Avanos Medical Inc (AVNS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.74 is considered Undervalued compared with the five-year average of 20.45. The fair price of Avanos Medical Inc (AVNS) is between 16.27 to 29.48 according to relative valuation methord. Compared to the current price of 11.94 USD , Avanos Medical Inc is Undervalued By 26.60% .
arrow icon

What is Avanos Medical Inc (AVNS) fair value?

arrow icon

How does AVNS's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Avanos Medical Inc (AVNS) as of Sep 01 2025?

arrow icon

What is the current FCF Yield for Avanos Medical Inc (AVNS) as of Sep 01 2025?

arrow icon

What is the current Forward P/E ratio for Avanos Medical Inc (AVNS) as of Sep 01 2025?

arrow icon

What is the current Forward P/S ratio for Avanos Medical Inc (AVNS) as of Sep 01 2025?